On May 12, 2025 Nusano, a physics company transforming the production of radioisotopes, reported its Chief Product Officer, Kevin Haehl, will participate in a radioisotope supply chain panel discussion at the 21st Annual PEGS (Protein & Antibody Engineering) Summit on Wednesday, May 14, 2025, in Boston (Press release, Nusano, MAY 12, 2025, View Source [SID1234652887]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Haehl is a 35-year veteran of the biotech and pharmaceutical manufacturing industries, with extensive experience in operations. During the panel, he will describe existing radiopharmaceutical supply chain constraints and explain how Nusano’s first-of-its-kind radioisotope production platform will deliver high volume, high purity radioisotopes to address existing needs and enable radiopharmaceutical innovation.

WHO:
Nusano Chief Product Officer, Kevin Haehl

WHAT:
Panel Discussion, Isotope Selection, Acquisition, and Production—Challenges and Opportunities

WHEN:
Wednesday, May 14, 2025
11:25 AM Eastern

WHERE:
21st Annual PEGS Summit, Omni Boston Hotel at the Seaport, Boston, MA